Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) EBIT: 2018-2020

Historic EBIT for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $733.4 million.

  • Genmab A's EBIT rose 245.22% to $199.61 in Q2 2021 from the same period last year, while for Jun 2021 it was $323.60, marking a year-over-year decrease of 100.00%. This contributed to the annual value of $733.4 million for FY2020, which is 167.33% up from last year.
  • Latest data reveals that Genmab A reported EBIT of $733.4 million as of FY2020, which was up 167.33% from $274.3 million recorded in FY2019.
  • Genmab A's EBIT's 5-year high stood at $733.4 million during FY2020, with a 5-year trough of $177.0 million in FY2018.
  • For the 3-year period, Genmab A's EBIT averaged around $394.9 million, with its median value being $274.3 million (2019).
  • Data for Genmab A's EBIT shows a peak YoY surged of 167.33% (in 2020) over the last 5 years.
  • Yearly analysis of 3 years shows Genmab A's EBIT stood at $177.0 million in 2018, then spiked by 54.98% to $274.3 million in 2019, then spiked by 167.33% to $733.4 million in 2020.